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Abstract 
 
The use of Dual Polarization Interferometry (DPI) as a tool for probing the 
different possible outcomes of protein crystallisation experiments is described. 
DPI is a surface analytical technique used for the characterisation of structure 
and interactions of molecular layers on an optical waveguide surface for a wide 
range of applications, including protein-protein interactions and conformational 
changes. The application of this technique provides a ‘signature’ of 
crystallisation events thus predicting if there will be protein crystal formation, 
amorphous precipitate or clear solution. The technique was demonstrated on a 
number of model proteins and it also produced meaningful results in the case of 
two problematic target proteins. DPI in conjunction with a dialysis setup, allows 
changes in the protein solution above the waveguide surface to be monitored 
simultaneously with continuous control of its precipitant content. DPI has the 
potential to be used as a powerful method for discovering crystallisation 
conditions, for obtaining information on the crystallisation process and as an aid 
in crystal optimisation. It has also provided what is, to the best of our knowledge, 
the most direct observation to date of salting in behaviour in a protein-salt 
solution. 
 
Introduction  
 
X-ray crystallography is the most widely used method for elucidating the three-
dimensional structures of biological macromolecules. It is the only method that allows 
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macromolecular structures to be solved up to atomic resolution and without a priori 
limitations on the size of the molecules. Success in crystallographic structure 
elucidation depends absolutely on success in obtaining well-diffracting crystals of the 
molecule or complex. This is a protracted process which is often unsuccessful. The 
great numbers of conditions that usually need to be blindly tried before promising 
results can be observed (if at all) and the corresponding requirements in large 
quantities of pure, highly concentrated macromolecular material, consumables, labour 
and incubation times, is a major stumbling block to the process1.  The problem is 
compounded by the fact that a condition which is close to success can be easily 
missed if the value of one of the parameters is even slightly outside the region where 
crystalline material would be distinguishable under a stereoscope. 
 
In this paper, we report the use of Dual Polarization Interferometry (DPI) as an 
effective diagnostic tool for protein crystallisation, which enables the early and 
efficient detection of conditions that are most likely to lead to crystals, more quickly 
and economically than by conventional screening. DPI is an optical waveguide 
technique which has been widely used for the measurement of the dimensions of 
surface molecular layers and their interactions2-4. The technique monitors the change 
of the velocity of propagation of two polarisations of light down a waveguide by 
measuring the change in the respective interference patterns output from the device. 
The interference is generated between an upper sensing and a buried lower reference 
waveguide as shown in Figure 1. Any change in the refractive index (RI) above the 
waveguide surface will change the velocity of propagation of the light and so change 
the phase position of the two sets of interference fringes.  
 
In general use, the phase changes are monitored, whereas the sharpness of the fringe 
pattern, i.e. contrast, which is related to the amount of light propagating along the 
waveguide, is not observed to change significantly. The contrast can however be 
expected to change due to loss of light from the waveguide, either because of optical 
absorption or by the presence of surface structures that scatter or couple light out of 
the waveguide. This latter effect has recently been shown to occur as a result of 
protein crystallisation5. Specifically, it had been shown that DPI enabled the real-time 
detection of early protein crystallisation events. Experiments were run using a batch 
method. The crystallisation solution was in contact with the ‘sensing’ waveguide and 
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the measured phase shift and contrast ratio of the interference fringes were shown to 
be sensitive to the deposition of a protein adlayer on the sensing waveguide and to 
crystallisation events at or near the solution-waveguide interface. Namely, a rather 
sharp drop in contrast accompanying the phase shift was observed at crystallisation 
conditions. However, the routine use of batch crystallisation with this technique has 
severe limitations. Only a limited amount of discrete trials can be performed and 
promising conditions can still easily be ‘missed’ in spite of the improved detection, 
because the concentration of an otherwise promising precipitant, or of the protein, 
might be already far too high at the outset. Furthermore, if precipitate has already 
formed in the solution bulk upon mixing and before insertion into the measurement 
cell, no signal (which is dependent on the deposition of protein or crystals on the 
waveguide) will be obtained. Therefore, the method has been adapted to dialysis, by 
effectively splitting the chamber in the horizontal direction by interposition of a 
dialysis membrane. 
 
 
 
 
 
 
 
Figure 1. Optical principle of Dual Polarisation Interferometry. Light from a sensing 
waveguide in contact with the investigated solution interferes with that from a reference 
waveguide, resulting in interference fringes characterised by their phase and contrast. 
 
 
In the present study we implemented DPI in a dialysis setup and applied it to five 
proteins, under crystallisation and non-crystallisation conditions. Lysozyme, catalase 
and thaumatin were used to validate the technique, and dynamin and xylanase were 
target proteins for which finding crystallisation conditions had proved to be 
problematic, thus it was needed to test if DPI would give an indication of whether 
crystallisation would take place. A dialysis approach enabled us to scan across a wide 
range of conditions (precipitant, pH etc.), continuously or step-wise, in one trial. We 
have examined in detail the differences between DPI measurements from crystallising 
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versus non-crystallising (clear and amorphously precipitating) protein solutions and 
have found what seems to be an unequivocal ‘signature’ of crystallisation events, 
which were also detected by direct microscopic observation. Dialysis experiments 
were set up at conditions known to lead to clear solutions, to crystallisation and to 
precipitation, as described below. The DPI dialysis method can be used to 
discriminate between the formations of crystalline versus amorphous material in real 
time as a function of precipitant concentration. Real-time DPI monitoring of such a 
trial can therefore indicate whether this particular precipitant or precipitant/buffer 
combination is worth pursuing and optimising for crystal production, as well as 
providing information for establishing a crystallisation phase diagram.  
 
Materials and Methods 
 
 Description of the DPI apparatus and crystallisation cells. 
 
The principles of construction and operation of the DPI apparatus are described in the 
Supporting Information.  
 
A special dialysis cell was constructed, to fit the DPI instrument (Analight Bio200, 
Farfield Group Ltd, Crewe, UK), as shown schematically in Figure S1 (Supporting 
Information). Above the optical waveguide chip surface a gasket with a cut-out 
channel was placed, which defined the sample sensing area above the chip. An inlet 
and an outlet allowed protein solution to be flowed through this channel, in contact 
with the sensing waveguide. Above this protein channel was bonded a defined pore 
size filter membrane (Millipore UK, Ultracell Ultrafiltration Disc, 5000 Molecular 
Weight cut-off, or 10000 MWCO for PEG solutions), above which a polyether ether 
ketone (PEEK) manifold block was clamped with a corresponding dialysis channel 
machined into it and provided with its own inlet and outlet tubing. The protein and 
dialysis channels were isolated from each other by the sandwiched membrane. This 
setup enabled independent solutions to be flowed either over the chip surface, or 
through the dialysis channel. This arrangement was duplicated to allow two side-by-
side experiments to be performed at any one time. Presently, one of the fluidic setups 
was used to perform a control experiment without protein. The channels are 15 mm 
long, with a width of 1 mm and depth of 0.5 mm. The volume of liquid contained in 
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the channel is therefore 7.5 μl but the loading routine and dead volumes used meant 
that 20 μl of protein sample had to be used per run. Subsequent developments have 
reduced the minimum volume of protein solution to approximately 10 μl per run. 
 
The bottom channel, in contact with the sensing waveguide, is filled with the protein 
solution (hence the ‘protein channel’), whereas the precipitant solution is injected into 
the higher channel (‘dialysis channel’) above the membrane. The precipitant solution 
can be either kept fixed in the upper part of the chamber for the whole duration of the 
trial, or replenished continuously or periodically, or it can be modified in response to 
the DPI measurements that are recorded during the trial. This has been achieved using 
an autosampler (Jasco AS-2055). 
 
An observation cell was also constructed, with the same geometry and dimensions as 
the measuring cell, in order to allow observation under the stereoscope of an identical 
experiment run outside the Analight instrument. In this case the sensor chip and 
fluidic block are replaced with glass plates.  
 
Crystallisation and control experiments 
 
Details of the proteins and chemicals used are provided in the Supporting Information.  
 
Due to the presence of the membrane and to the dialysis delay time, the precipitant 
concentration at the chip surface had to be determined by a calibration procedure, 
described in the Supporting Information. This calibration was used to convert from 
plots of phase shift and contrast against time, to plots against calibrated salt 
concentration (e.g. Figure 2).  
 
The chip temperature was controlled using a two-stage Peltier thermoregulator built 
into the Analight instrument, which allows control between 15 and 40°C with an 
accuracy of approximately 0.5°C. All experiments were carried out at 20°C.  
 
Lysozyme. Different lysozyme solutions (5, 10, 20 and 30 mg/ml) in 50 mM sodium 
acetate at pH 4.6 were dialysed against same buffer solutions of NaCl concentrations 
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varying from 1% to 20% (w/v). The salt solutions were injected into the precipitant 
channel in 1% (w/v) increments for 20-30 minutes each (Table 1). 
 
Catalase. A catalase solution in 100 mM Tris at pH 7.5 was dialysed against a 30% 
(w/v) PEG 6000, 5% (v/v) MPD solution in the same buffer.  The PEG dialyses 
slowly through the 10000 Molecular Weight cut-off membrane and therefore the 
protein solution is exposed to a continuous range of PEG concentrations, without the 
need to step up by successive precipitant injections. Two experimental runs were 
performed with protein concentrations of 12 mg/ml and 14 mg/ml (Table 1), 
corresponding to the crystallisation range of conditions for catalase6, 7. These were 
also checked by setting up parallel experiments, initially in microbatch under oil and 
later in the observation cell. A catalase trial leading to clear solution (14 mg/ml 
protein dialysed against 30% (w/v) NaCl) was also performed.   
 
Thaumatin. Three types of experiment were run (Table 1): 
(i) At well-known crystallisation conditions, ranging from 10 mg/ml to 25 mg/ml 
thaumatin in 50 mM PIPES buffer at pH 6.8, dialysed against sodium potassium 
tartrate at concentrations from 0.1 M up to 2 M in the same buffer8. 
(ii) At conditions similar to ones reported in the literature to produce crystals, 40 
mg/ml protein in 50 mM PIPES buffer, pH 6.8, dialysed against 0.5 M to 3 M 
ammonium sulphate9, 10. However, these only produced precipitate when tried in 
the observation cell. 
(iii) At conditions leading to amorphous precipitation, 16 mg/ml thaumatin in 50 
mM PIPES, pH 6.8, dialysed against 0.5 M to 2.5 M sodium chloride. These 
conditions have never been reported to yield thaumatin crystals and they have 
also been verified in our laboratory to give rise to amorphous precipitate. 
 
Rat Dynamin. Protein at a stock concentration of 4.5 mg/ml in 20 mM PIPES, 20 
mM HEPES, pH 7, with 1mM EGTA, 150 mM NaCl, 2 mM MgCl2 and 5 mM 
dithiothreitol was dialysed against the same buffer solutions with NaCl concentrations 
varying from 150 mM to 2 M. 
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Xylanase. Protein at 12 mg/ml in a buffer of 20mM Tris HCl at pH 7 and 100 mM 
NaCl was dialysed against a buffer of 0.1 M sodium cacodylate at pH 6.5 and 100mM 
NaCl with ammonium sulphate concentration varying from 0 to 2.8 M.  
 
Results and Discussion 
 
 
Discrimination of crystallising versus non-crystallising protein solutions 
 
Lysozyme. In order to benchmark the technique and validate the practical process, 
experiments were first performed using lysozyme. Four different trials at varying 
protein concentrations were run (Table 1). In all cases, it was observed that, in the 
earlier stages of the dialysis (Figures 2 and S2, Supporting Information), the phase 
shift of the protein solution dialysing against NaCl was smaller than that in the buffer 
solution. We believe this region of slower phase change to correspond to the salting in 
region11, where salt binds the protein molecules thus preventing them from forming 
aggregates in solution and also possibly reducing and reversing their electrostatically 
driven physisorption on the waveguide surface. Thus at low NaCl concentrations, 
lysozyme that is initially adsorbed to the surface upon initial injection (Figure S2, 
Supporting Information) starts desorbing due to the electrostatic shielding of the salt. 
Because the phase change due to the increasing bulk contribution from the salt is 
higher than the contribution from the desorbing protein, the phase does still increase, 
but at a lower rate than observed for the control channel. As the amount of salt 
increases further, more protein starts depositing on the surface, leading to a net 
increase in the phase change above that observed for just salt: this corresponds to the 
onset of salting-out. This is, to the best of our knowledge, the most direct observation 
to date of salting in behaviour and the transition from salting-in to salting-out in a 
protein-salt solution. 
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Figure 2. Early stages of an experiment with lysozyme (5 mg/ml) dialysed against sodium 
chloride (0-11% (w/v). Difference in phase change between the protein channel and the 
control (buffer) channel as a function of calibrated salt concentration. The negative change at 
low concentrations indicates a slower phase shift for the protein solution as compared to the 
buffer. The two traces are measurements of TM phase changes at different positions within 
the protein channel.  
 
The trial at 5 mg/ml lysozyme displayed a gradual phase shift and no drop in fringe 
contrast. Indeed, we always observe 5 mg/ml lysozyme solutions to remain clear 
throughout the tested range of NaCl concentrations. 
The other three trials, with more concentrated protein (10-30 mg/ml), displayed a 
sharp increase in phase approximately coinciding with a very sharp drop in the fringe 
contrast (Figure 3), at different calibrated salt concentrations: the more concentrated 
the protein solution, the lower the salt concentration at which the discontinuity 
occurred, as expected, since more concentrated protein solutions need less salt to 
reach supersaturation and spontaneous nucleation conditions.  
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Figure 3. TM and TE phase shifts and contrasts for a 30 mg/ml lysozyme solution dialysed 
against NaCl, versus time. The injected NaCl concentrations (1-13 %(w/v)) are indicated in 
white boxes above the phase shift curves. The control channel measurements are not shown. 
 
Catalase. Both experimental runs, at 12 mg/ml (Figure S3, Supporting Information) 
and at 14 mg/ml catalase, displayed a marked increase in phase in tandem with a 
sharp loss of contrast at crystallisation conditions, as opposed to runs performed at 
conditions leading to clear solutions (Figure S4, Supporting Information). The latter 
led to a very small phase increase over and above the NaCl solution alone, due to a 
low level of protein deposition on the chip, and to no loss of contrast.  
 
Thaumatin. Three experimental runs at various thaumatin concentrations were 
performed at sodium potassium tartrate conditions in the presence of PIPES at pH 6.8, 
which are the most common conditions for thaumatin crystallisation (Table 1). All 
runs showed an increase in phase coupled with an abrupt loss of contrast.  
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Figure 4. Phase and contrast for a 40 mg/ml thaumatin solution in PIPES, pH 6.8, dialysed 
against 0.5 to 3 M ammonium sulphate. 
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Two more runs performed without tartrate, in which 40 mg/ml protein was dialysed 
against 0.5 to 3 M ammonium sulphate in the same buffer (Figure 4) produced similar 
results as with sodium tartrate, i.e. an increase in phase accompanied by loss of 
contrast, though not as sharp as in the tartrate experiments. Although it was not 
expected that thaumatin would crystallise without tartrate, similar crystallisation 
conditions had in fact been reported in the past (20 mg/ml protein, 2-2.5 M 
ammonium sulphate, 50 mM HEPES, pH 7.0, at 20°C in vapour diffusion9, 10). 
Standard vapour diffusion hanging drop trials were set up around these conditions for 
verification and produced microcrystals when 20 mg/ml protein was mixed in equal 
volumes (2μl + 2μl) and equilibrated against a solution of 0.75 M – 1.0 M ammonium 
sulphate in 50 mM HEPES, pH 7.0, at 20°C.  This result exemplifies the usefulness of 
DPI in “discovering” what was in fact to us an “unknown” crystallisation condition 
and showing that we were in fact working very near crystallisation conditions (but 
presumably at too high supersaturation) . 
 
Two runs were also performed at conditions known to induce amorphous 
precipitation. They consisted of 16 mg/ml protein in PIPES, pH 6.8, dialysed against 
0.5 to 2.5 M sodium chloride in the same buffer. In both cases, the phase shift was not 
accompanied by contrast loss (Figure 5). Immediately after the end of the first run, the 
DPI cell was dismantled and the protein solution inside was examined. It was 
observed that moderate precipitation had already taken place. In the second run, the 
dialysis was reversed after reaching the maximum salt concentration, i.e. the protein 
solution was dialysed against buffer. This resulted in a reduction in the phase shift 
attributable to the salt. However most of the additional phase change due to protein 
aggregation was not eliminated, indicating that a large portion of the protein was not 
redissolved (approximately 80%) and had been irreversibly deposited. This indicates 
that the reversibility of the deposition process can be assessed with this method, 
which potentially provides an additional means of discriminating between forms of 
deposited material.  
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Figure 5.  Phase and contrast for a 16 mg/ml thaumatin solution in PIPES pH 6.8, dialysed 
against 0.5-2.5 M NaCl in the same buffer. Under these conditions the protein precipitates 
amorphously. 
 
Trials with problematic target proteins 
 
Having validated the technique using the above proteins, we tested the applicability of 
the DPI to two proteins, one which has not given crystals after several years of trials 
and another which had been recalcitrant to producing crystals for several years and for 
which successful crystallisation conditions have recently been discovered.  
 
Rat Dynamin. Rat dynamin does not crystallise despite extensive trials and is used 
here a negative control with NaCl as precipitant. Figure 6 shows the phase and 
contrast changes for the dialysis against sodium chloride. The phase increase observed 
corresponds solely to the increasing NaCl concentration and no protein deposition is 
observed. In fact the protein response does not increase as much as the control 
channel, indicating desorption of the initially adsorbed protein monolayer from the 
chip surface as a result of increasing salt concentration. This process can be seen to be 
starting to reverse as the salt is dialysed back out at the end of the experiment. The 
contrast in either channel does not drop during the whole experiment.  
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Figure 6.  Phase and contrast for Rat Dynamin at 4.5 mg/ml dialysed against the same buffer 
containing NaCl to a final concentration of 2 M. The NaCl is then rinsed back out by dialysis 
against the buffer. 
 
Xylanase. Xylanase is a target protein that had proved difficult to crystallise until 
recently, when this was achieved with crystals forming in 0.5 M - 1 M ammonium 
sulphate and 50 – 100 mM NaCl. Figure 7 shows the DPI with dialysis result for this 
crystallisation condition. Apart from the initial phase increase on introduction of the 
stock protein solution, due to bulk refractive index change from the protein and 
monolayer adsorption, the ammonium sulphate driven deposition of xylanase on the 
chip can be seen to start taking place at the arrow marked A. This corresponds to 0.5 
M ammonium sulphate, as calibrated using the control channel response, and is at the 
lower end of the crystallisation conditions. The upper end of the range was 1 M 
ammonium sulphate and is marked by the second arrow (B). The contrast is observed 
to start dropping just above this concentration, and the interference fringes are almost 
completely extinguished by the time the phase change has reached a plateau at 2.8 M 
ammonium sulphate. 
 
Crystals of xylanase could only be obtained by using unconventional crystallisation 
methods that allowed slow and well-controlled increase of the precipitant 
concentration in the crystallisation solution, namely capillary counterdiffusion12 and a 
modified version of vapour diffusion13. Crystallisation conditions were therefore 
altogether missed in standard vapour diffusion and microbatch trials. In contrast, the 
DPI with dialysis method, which is sensitive to the presence of microcrystals and 
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allows the crystallisation process to be driven through a range of precipitant 
concentrations, was capable of clearly identifying a promising crystallisation 
condition.  
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Figure 7.  Phase and contrast for 12 mg/ml xylanase in 20mM Tris HCl, 100mM NaCl, pH 
7.0, dialysed against 0.5 to 2.8 M ammonium sulphate in 0.1 M sodium cacodylate, pH 6.5, 
100 mM NaCl. The ammonium sulphate concentration in the protein channel reaches 2.75 M 
during the experiment. 
 
 
Characteristic stages in the crystallisation process 
 
DPI measurements can further be used for the description of the crystallisation 
process. Studying the data in greater detail, it is possible to distinguish the different 
stages of protein adsorption, association and eventually crystallisation (if it occurs). 
The following stages are presented in the order they typically occur and can be 
observed by the present dialysis experiments.   
 
A) Physisorption of protein to surface (small phase increase, Figure S2, 
Supporting Information). 
B) Desorption of protein from surface due to electrostatic shielding of salt – 
salting in (Figure 2). 
C) Increase in bulk refractive index of the solution due to increasing salt 
concentration (phase increase – same slope for control and protein channels, 
Figure 2, 5-7% NaCl). 
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D) Association of protein at the surface (the slope of the  phase change on the 
protein channel increases above that of the control channel, Figure 3, 3-11% 
NaCl) 
E) Loss of fringe contrast - Crystal Nucleation (Figures 3, 4, S3, Supporting 
Information) 
F) Large / Rapid increase in phase shift - Protein precipitation (Figures 5, S4, 
Supporting Information) 
G) Decrease in phase shift on incubation post-crystallisation is occasionally 
observed and could be attributed to dissolution of precipitate or microcrystals 
if larger crystals are growing outside the measurement path.  
 
Some of the above phenomena can be summarized in the form of a phase diagram 
analogue. Figure 8 presents such a “phase diagram” (thin lines) for lysozyme, 
superimposed on a more traditional crystallisation phase diagram obtained by a fine 
screening of conditions in microbatch drops (thick lines). The latter was established as 
described in14, 15. The arrow shows the direction in which the dialysis setup allows the 
conditions to be scanned, sampling across a wide range of the phase diagram.  
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Figure 8. Phase diagram analogue obtained with DPI (thin lines) for lysozyme, compared 
with working phase diagram obtained in microbatch (thick lines) and with solubility data 
from Ataka & Tanaka16 and Cacciopo & Pusey17.  
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The initial onset curve (Figure 8, in cyan) is the point where the phase shift on the 
protein channel starts increasing faster than the phase shift on the control channel 
(stage D above). It indicates the start of aggregation of the protein at the chip surface. 
This is expected to be somewhat above the soluble-metastable boundary (i.e. the 
solubility curve) but below the metastable-nucleation zone boundary (the 
supersolubility curve), since deposition of protein molecules on the chip surface 
requires supersaturation, but most probably at a lower level than that required for 
nucleation in the solution bulk. It is observed that at higher protein concentrations the 
initial onset curve is indeed at higher precipitant concentrations than the soluble-
metastable boundary obtained from microbatch experiments. The former though, 
displays a much sharper slope from 30 mg/ml to 10 mg/ml lysozyme; the two curves 
thus cross at 18 mg/ml protein and 4% (w/v) NaCl, after which the initial onset curve 
corresponds to lower precipitant concentrations than the microbatch soluble-
metastable boundary. However, comparison of the initial onset curve with solubility 
curves obtained by Ataka & Tanaka16 and by Cacciopo & Pusey17 shows that the 
overall shape of these is much more similar to the initial onset curve than the 
corresponding microbatch curve. As expected, the initial onset curve is above the 
solubility curves determined both by Ataka & Tanaka (at 15°C) and by Cacciopo & 
Pusey (at 20°C), i.e. it corresponds to higher salt concentrations at solubility. Ataka & 
Tanaka16 as well as Cacciopo & Pusey17 use accurate methods of measuring the true 
solubility of the protein, consisting in re-dissolving crystals in undersaturated 
solutions as well as growing them in supersaturated ones. The method used in the 
microbatch experiments is a much faster one, which does not involve re-dissolving of 
crystals and leads to what has been dubbed a “working phase diagram”. It appears that 
the DPI initial onset curve, whilst not coinciding with the solubility curve, may 
provide a useful indication of the overall features of the [precipitant]-[protein] 
dependency. Potentially, a true solubility curve could be obtained with this technique 
if, after nucleation has taken place, the dialysis were then reversed to determine the 
point at which the crystalline material starts redissolving.  
 
The inflection 1 curve (Figure 8, in green) corresponds to the point at which the phase 
starts to increase rapidly (indicative of rapid aggregation, stage F above) thus it 
corresponds to the boundary of the precipitation region. At low protein concentration 
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this corresponds closely with the microbatch values but at higher protein 
concentration it is at a higher salt concentration than the latter. This discrepancy could 
be expected due to the “shock nucleation” effect in microbatch at high protein 
concentrations, when nuclei form at the interface where the two highly concentrated 
protein and precipitant solutions come into contact. Shock nucleation leads to an 
underestimation of the salt concentrations needed for protein precipitation15.  
 
Conclusions 
 
With the DPI dialysis technique, it is possible with a fixed sample volume, to scan 
through a wide precipitant concentration range in a relatively short period of time. It 
can be used to monitor the initial adsorption of protein to the optical chip surface, 
salting-in, aggregation onto the surface, nucleation, precipitation and crystal 
formation, all as a function of precipitant concentration. Similar measurements could 
of course readily also be extended to additives or pH, as well as temperature which 
can already be dynamically controlled with the instrumentation. The experiments 
performed in this study offer a strong indication that DPI may reliably distinguish 
between nucleation-crystallisation events and mere amorphous aggregation events. A 
DPI “signature” of crystallisation, namely a fairly sharp loss of contrast 
accompanying the phase shift, was a feature of all trials performed where crystals 
were obtained or which were close to conditions where crystals can be obtained. In 
contrast, no appreciable contrast loss occurred when the trials led to either clear 
solutions or amorphous precipitation. 
 
This has been validated against three different model proteins and two target proteins 
which show different crystallizing, and non-crystallising, behaviours. DPI can 
therefore be used as a powerful diagnostic tool for discovering and selecting 
promising crystallisation conditions, for distinguishing microcrystalline from 
amorphous precipitate (a very difficult task even for experienced crystallographers), 
and for collecting useful information for crystal optimisation as well as for the study 
of crystallogenesis. 
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Protein conc. 
(mg/ml) 
Precipitant  Result Phase shift Contrast 
drop 
Lysozyme (in 50 mM Na acetate, pH 4.6) 
5 1-19%(w/v) NaCl clear Yes 
(gradual) 
No 
10  1-20%(w/v) NaCl crystals Yes Yes 
20 1-17%(w/v) NaCl crystals Yes Yes 
30 1-13%(w/v) NaCl crystals Yes Yes 
Catalase (in 100 mM Tris, pH 7.5) 
12 30%(w/v) PEG 6000 crystals Yes Yes 
14 30%(w/v) PEG 6000 crystals Yes Yes 
14 30%(w/v) NaCl clear Marginal No 
Thaumatin (in 50 mM PIPES, pH 6.8) 
10 0.1-2.0 M Na/K tartr. crystals Yes Yes 
15 0.1-1.6 M Na/K tartr. crystals Yes Yes 
25 0.1-1.8 M Na/K tartr. crystals Yes Yes 
40 0.5-3.0 M amm. 
sulphate 
microcrystals 
(see text) 
Yes Yes 
16 0.5-2.5 M NaCl precipitation Yes No 
Dynamin (in 20mM PIPES pH 7, 1mM EGTA, 150 mM NaCl, 2 mM MgCl2) 
4.5 0.15-2 M NaCl clear No No 
Xylanase (in  20mM Tris pH 7, 100mM NaCl)  
12 0-2.8 M amm. 
sulphate 
microcrystals Yes Yes 
 
Table 1. Summary of the crystallisation trials and corresponding DPI 
observations. 
